18 Recruiting Triple Negative Breast Cancer (TNBC) Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Triple Negative Breast Cancer (TNBC)
Top Recruiting Triple Negative Breast Cancer (TNBC) Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer
📍 RWJBarnabas Health - Trinitas hospital and Comprehensive Center — Elizabeth, New Jersey
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)
📍 SUNY Upstate Medical University — Syracuse, New York
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
📍 START Midwest — Grand Rapids, Michigan
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program
A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔